{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:33:22Z","timestamp":1775320402515,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012256","name":"Research Foundation of Cerebral Palsy Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.braindev.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T11:38:53Z","timestamp":1635161933000},"page":"153-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Autosomal dominant ADAR c.3019G>A (p.(G1007R)) variant is an important mimic of hereditary spastic paraplegia and cerebral palsy"],"prefix":"10.1016","volume":"44","author":[{"given":"Hannah F.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladys","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dugald","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Velda X.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Paget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavitha","family":"Kothur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Troedson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanick J.","family":"Crow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell C.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shekeeb S.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2021.10.001_b0005","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.braindev.2021.10.001_b0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jid.2015.12.034","article-title":"Dyschromatosis symmetrica hereditaria and Aicardi-Goutieres syndrome 6 are phenotypic variants caused by ADAR1 mutations","volume":"136","author":"Kono","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.braindev.2021.10.001_b0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.braindev.2015.11.007","article-title":"Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome","volume":"38","author":"Pranzatelli","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2021.10.001_b0020","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1056\/NEJMc2001362","article-title":"Janus kinase inhibition in the Aicardi-Goutieressyndrome","volume":"383","author":"Vanderver","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2021.10.001_b0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-0037-1601449","article-title":"Genetic, phenotypic, and interferon biomarker status in ADAR1-related neurological disease","volume":"48","author":"Rice","year":"2017","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.braindev.2021.10.001_b0030","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview","volume":"213","author":"Rodero","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.braindev.2021.10.001_b0035","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/mds.21011","article-title":"Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation","volume":"21","author":"Tojo","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.braindev.2021.10.001_b0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.parkreldis.2020.08.039","article-title":"Movement disorders in ADAR1 disease: Insights from a comprehensive cohort","volume":"79","author":"Di Lazzaro","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.braindev.2021.10.001_b0045","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/MOP.0b013e3283402b71","article-title":"Biomarkers of inflammatory and auto-immune central nervous system disorders","volume":"22","author":"Dale","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.braindev.2021.10.001_b0050","article-title":"Cerebrospinal fluid neopterin as a biomarker of treatment response to Janus kinase inhibition in Aicardi-Goutieres syndrome","author":"Han","year":"2021","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2021.10.001_b0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Goutieres syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.braindev.2021.10.001_b0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jmedgenet-2013-102038","article-title":"A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1","volume":"51","author":"Livingston","year":"2014","journal-title":"J Med Genet"},{"key":"10.1016\/j.braindev.2021.10.001_b0065","unstructured":"Mohammad SS, Angiti RR, Biggin A, Morales-Briceno H, Goetti R, Perez-Duenas B, et al. Magnetic resonance imaging pattern recognition in childhood bilateral basal ganglia disorders. Brain Commun 2020;2:fcaa178."},{"key":"10.1016\/j.braindev.2021.10.001_b0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mdc3.12903","article-title":"Diagnosis of Aicardi-Goutieres syndrome in adults: a case series","volume":"7","author":"Videira","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.braindev.2021.10.001_b0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/archdischild-2020-319541","article-title":"Psychiatric comorbidity is common in dystonia and other movement disorders","volume":"106","author":"Lorentzos","year":"2021","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.braindev.2021.10.001_b0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/dmcn.14268","article-title":"Treatments in Aicardi-Goutieres syndrome","volume":"62","author":"Crow","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2021.10.001_b0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1212\/WNL.0000000000004921","article-title":"An open-label trial of JAK 1\/2 blockade in progressive IFIH1-associated neuroinflammation","volume":"90","author":"Kothur","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2021.10.001_b0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/1744666X.2019.1707663","article-title":"Novel and emerging treatments for Aicardi-Goutieres syndrome","volume":"16","author":"Tonduti","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.braindev.2021.10.001_b0095","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41588-020-00737-3","article-title":"cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing","volume":"52","author":"Uggenti","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.braindev.2021.10.001_b0100","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/humu.23975","article-title":"Genetic and phenotypic spectrum associated with IFIH1 gain-of-function","volume":"41","author":"Rice","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.braindev.2021.10.001_b0105","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1","volume":"167A","author":"Crow","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.braindev.2021.10.001_b0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/kes181","article-title":"Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome\/familial chilblain lupus","volume":"52","author":"Abe","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.braindev.2021.10.001_b0115","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.0022-202X.2005.23732.x","article-title":"Mutation analysis of the ADAR1 gene in dyschromatosis symmetrica hereditaria and genetic differentiation from both dyschromatosis universalis hereditaria and acropigmentatio reticularis","volume":"124","author":"Suzuki","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.braindev.2021.10.001_b0120","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1346-8138.2008.00540.x","article-title":"Dyschromatosis symmetrica hereditaria associated with neurological disorders","volume":"35","author":"Kondo","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.braindev.2021.10.001_b0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1346-8138.2008.00493.x","article-title":"Six novel mutations of the ADAR1 gene in patients with dyschromatosis symmetrica hereditaria: histological observation and comparison of genotypes and clinical phenotypes","volume":"35","author":"Kondo","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.braindev.2021.10.001_b0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2340\/0001555574138139","article-title":"Dyschromatosis symmetrica hereditaria associated with idiopathic torsion dystonia. A case report","volume":"74","author":"Patrizi","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.braindev.2021.10.001_b0135","first-page":"299","article-title":"A case of didiopathic brain calcification associated with dyschromatosis symmetrica hereditaria, aplasia of dental root, and aortic valve sclerosis","volume":"41","author":"Tojyo","year":"2001","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.braindev.2021.10.001_b0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4103\/0378-6323.53154","article-title":"Acral dyschromatosis with developmental regression and dystonia in a seven-year-old child: dyschromatosis symmetrica hereditaria variant or a new syndrome?","volume":"75","author":"Kaliyadan","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.braindev.2021.10.001_b0145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4103\/0378-6323.144191","article-title":"Dyschromatosis symmetrica hereditaria with neurological abnormalities","volume":"80","author":"Dutta","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760421001856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760421001856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:50:45Z","timestamp":1759953045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760421001856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0387760421001856"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2021.10.001","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autosomal dominant ADAR c.3019G>A (p.(G1007R)) variant is an important mimic of hereditary spastic paraplegia and cerebral palsy","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}